Altamira Therapeutics Ltd. (CYTOF)
OTCMKTS
· Delayed Price · Currency is USD
0.120
-0.180 (-60.00%)
Dec 20, 2024, 4:00 PM EST
Altamira Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -2.7 | -3.87 | -26.53 | -17.06 | -8.2 | -6.63 | Upgrade
|
| Depreciation & Amortization | 0.13 | 0.12 | 0.12 | 0.08 | 0.02 | 0.03 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | 12.4 | 1.53 | - | - | Upgrade
|
| Loss (Gain) on Equity Investments | 0.28 | 0.04 | - | - | - | - | Upgrade
|
| Stock-Based Compensation | 0.48 | 0.38 | 0.34 | 1.21 | 0.37 | 0.23 | Upgrade
|
| Other Operating Activities | 0.78 | 1.37 | 1.5 | 0.94 | 2.67 | -0.79 | Upgrade
|
| Change in Accounts Receivable | 0.05 | 0.01 | -0.1 | -0.34 | 0.25 | -0.02 | Upgrade
|
| Change in Inventory | -0.07 | -0.32 | 0.83 | -0.84 | - | - | Upgrade
|
| Change in Accounts Payable | -0.45 | -3.3 | 1.26 | 2.94 | -0.18 | -0.9 | Upgrade
|
| Change in Other Net Operating Assets | -0.17 | -0.64 | 1.57 | -1.58 | 0.22 | -0.31 | Upgrade
|
| Operating Cash Flow | -7.58 | -11.51 | -8.68 | -13.67 | -4.84 | -8.39 | Upgrade
|
| Capital Expenditures | - | - | - | - | - | -0.06 | Upgrade
|
| Divestitures | 2.14 | 1.92 | - | - | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | -2.14 | -3.33 | -2.32 | -2.96 | Upgrade
|
| Investment in Securities | -0.53 | -0.48 | - | -0.18 | - | - | Upgrade
|
| Other Investing Activities | 0 | 0 | 0 | - | 0 | 0.02 | Upgrade
|
| Investing Cash Flow | 1.61 | 1.44 | -2.14 | -3.51 | -2.31 | -3 | Upgrade
|
| Short-Term Debt Issued | - | 2.5 | 6.04 | - | 1.52 | - | Upgrade
|
| Total Debt Issued | 0.04 | 2.5 | 6.04 | - | 1.52 | - | Upgrade
|
| Short-Term Debt Repaid | - | -1.34 | - | -0.05 | - | -1.46 | Upgrade
|
| Long-Term Debt Repaid | - | -0.12 | -0.11 | -0.02 | - | - | Upgrade
|
| Total Debt Repaid | -1.52 | -1.45 | -0.11 | -0.07 | - | -1.46 | Upgrade
|
| Net Debt Issued (Repaid) | -1.47 | 1.05 | 5.92 | -0.07 | 1.52 | -1.46 | Upgrade
|
| Issuance of Common Stock | 8.31 | 10.51 | 3.96 | 6.84 | 16.07 | 9.79 | Upgrade
|
| Other Financing Activities | -0.91 | -0.93 | -0.05 | -0.16 | -0.64 | -0.95 | Upgrade
|
| Financing Cash Flow | 5.92 | 10.62 | 9.83 | 6.61 | 16.96 | 7.38 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.02 | 0.05 | 0.02 | 0.29 | 0.07 | 0.01 | Upgrade
|
| Net Cash Flow | -0.04 | 0.6 | -0.97 | -10.27 | 9.87 | -4.01 | Upgrade
|
| Free Cash Flow | -7.58 | -11.51 | -8.68 | -13.67 | -4.84 | -8.46 | Upgrade
|
| Free Cash Flow Per Share | -5.35 | -23.43 | -190.69 | -412.87 | -322.15 | - | Upgrade
|
| Cash Interest Paid | 0.15 | 0.15 | 0.02 | 0 | - | 0 | Upgrade
|
| Levered Free Cash Flow | -5.41 | -9.18 | -2.6 | -7.11 | -4.45 | -8.48 | Upgrade
|
| Unlevered Free Cash Flow | -5.05 | -8.53 | -2.03 | -7.1 | -4.37 | -8.46 | Upgrade
|
| Change in Net Working Capital | 0.96 | 4.95 | -3.5 | 0.51 | -0.86 | 1.17 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.